Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|February 10, 2016
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2CRachel Ulferts, S Matthijn de Boer, Lonneke van der Linden, et al.
Antiviral Research|January 8, 2014
Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteasesLonneke van der Linden, Rachel Ulferts, Sander B Nabuurs, et al.
The Journal of General Virology|June 16, 2026
A stable subgenomic reporter coronavirus enables transcriptional profiling of bystander cellsCiaran Gilbride, Joe Hemsley-Taylor, Catarina Nunes, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicaseJingkun Zeng, Florian Weissmann, Agustina P Bertolin, et al.
Journal of Virology|May 8, 2021
Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 GenomeValeria Lulla, Michal P Wandel, Katarzyna J Bandyra, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonucleaseBerta Canal, Allison W McClure, Joseph F Curran, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like proteaseChew Theng Lim, Kang Wei Tan, Mary Wu, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main proteaseJennifer C Milligan, Theresa U Zeisner, George Papageorgiou, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferaseSouradeep Basu, Tiffany Mak, Rachel Ulferts, et al.
Pageof 4